News & Insights
December 9, 2020
Press Release - Aqemia receives support and funding from Sanofi to apply its disruptive technology against COVID-19
Aqemia announces an agreement with the pharmaceutical company Sanofi to contribute to the discovery of effective treatments for COVID-19. As part of this agreement, Aqemia will apply its generative AI combined with its disruptive proprietary algorithms for affinity calculation between therapeutic targets and drug candidates.